Michael Andrew Chambers - Net Worth and Insider Trading
Michael Andrew Chambers Net Worth
The estimated net worth of Michael Andrew Chambers is at least $36 Million dollars as of 2024-12-28. Michael Andrew Chambers is the Director of Sarepta Therapeutics Inc and owns about 292,311 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $36 Million. Details can be seen in Michael Andrew Chambers's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Andrew Chambers has not made any transactions after 2024-08-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Andrew Chambers
Michael Andrew Chambers Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Andrew Chambers owns 1 companies in total, including Sarepta Therapeutics Inc (SRPT) .
Click here to see the complete history of Michael Andrew Chambers’s form 4 insider trades.
Insider Ownership Summary of Michael Andrew Chambers
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SRPT | Sarepta Therapeutics Inc | 2024-08-16 | director |
Michael Andrew Chambers Latest Holdings Summary
Michael Andrew Chambers currently owns a total of 1 stock. Michael Andrew Chambers owns 292,311 shares of Sarepta Therapeutics Inc (SRPT) as of August 16, 2024, with a value of $36 Million.
Latest Holdings of Michael Andrew Chambers
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics Inc | 2024-08-16 | 292,311 | 121.50 | 35,515,787 |
Holding Weightings of Michael Andrew Chambers
Michael Andrew Chambers Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Andrew Chambers has made a total of 6 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Sarepta Therapeutics Inc is the acquisition of 37,038 shares on August 16, 2024, which cost Michael Andrew Chambers around $5 Million.
Insider Trading History of Michael Andrew Chambers
- 1
Michael Andrew Chambers Trading Performance
GuruFocus tracks the stock performance after each of Michael Andrew Chambers's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Andrew Chambers is -13.09%. GuruFocus also compares Michael Andrew Chambers's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Andrew Chambers within 3 months outperforms 2 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Andrew Chambers's insider trading performs compared to the benchmark.
Performance of Michael Andrew Chambers
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.63 | | | | | |
| Relative Return to S&P 500(%) | 8.12 | | | | | |
Michael Andrew Chambers Ownership Network
Michael Andrew Chambers Owned Company Details
What does Sarepta Therapeutics Inc do?
Who are the key executives at Sarepta Therapeutics Inc?
Michael Andrew Chambers is the director of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Financial Officer Ian Michael Estepan , Chief Tech Ops Officer Bilal Arif , and SVP & General Counsel Ryan Edward Brown .
Sarepta Therapeutics Inc (SRPT) Insider Trades Summary
Over the past 18 months, Michael Andrew Chambers made 4 insider transaction in Sarepta Therapeutics Inc (SRPT) with a net purchase of 105,570. Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net sale of 40,500 shares made by Wigzell Hans Lennart Rudolf , a net sale of 40,957 shares made by Ryan Edward Brown , and a net sale of 13,757 shares made by Bilal Arif .
In summary, during the past 3 months, insiders sold 12,136 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 0 shares, with a net sale of 12,136 shares. During the past 18 months, 111,566 shares of Sarepta Therapeutics Inc (SRPT) were sold and 180,795 shares were bought by its insiders, resulting in a net purchase of 69,229 shares.
Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sarepta Therapeutics Inc Insider Transactions
Michael Andrew Chambers Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Andrew Chambers. You might contact Michael Andrew Chambers via mailing address: 215 First Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
